Key statistics
On Friday, Nautilus Biotechnology Inc (NAUT:NSQ) closed at 2.49, 13.70% above the 52 week low of 2.19 set on Jun 24, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.67 |
---|---|
High | 2.68 |
Low | 2.44 |
Bid | 2.42 |
Offer | 2.63 |
Previous close | 2.66 |
Average volume | 97.80k |
---|---|
Shares outstanding | 125.56m |
Free float | 70.75m |
P/E (TTM) | -- |
Market cap | 312.65m USD |
EPS (TTM) | -0.561 USD |
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
- Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research’s Distinguished Investigator Award
- Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference
- Nautilus Biotechnology Reports Third Quarter 2024 Financial Results
- Nautilus Biotechnology to Announce Third Quarter 2024 Financial Results on October 29, 2024
- Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer
- Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
- Nautilus Biotechnology Reports Second Quarter 2024 Financial Results
- Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024
- Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
- Nautilus Biotechnology Reports First Quarter 2024 Financial Results
More ▼